Page last updated: 2024-09-05

sorafenib and Bone Marrow Neoplasms

sorafenib has been researched along with Bone Marrow Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, SH; Civin, C; Collector, M; Heiser, D; Huso, D; Kaplan, I; Li, L; Sharkis, SJ; Small, D1

Other Studies

1 other study(ies) available for sorafenib and Bone Marrow Neoplasms

ArticleYear
FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm.
    Cell stem cell, 2012, Sep-07, Volume: 11, Issue:3

    Topics: Animals; Bone Marrow; Bone Marrow Neoplasms; Cell Compartmentation; Cell Cycle; Cell Proliferation; Enzyme Activation; Female; fms-Like Tyrosine Kinase 3; Gene Duplication; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Homeostasis; Male; Mice; Neoplastic Stem Cells; Niacinamide; Phenotype; Phenylurea Compounds; Promoter Regions, Genetic; RNA, Messenger; Side-Population Cells; Signal Transduction; Small Molecule Libraries; Sorafenib; Tandem Repeat Sequences

2012